These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36395587)
21. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895 [TBL] [Abstract][Full Text] [Related]
22. Opioid use and dependence among persons with migraine: results of the AMPP study. Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775 [TBL] [Abstract][Full Text] [Related]
23. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Buse DC; Serrano D; Holland S; Reed ML Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870 [TBL] [Abstract][Full Text] [Related]
24. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869 [TBL] [Abstract][Full Text] [Related]
25. Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy. Lipton RB; Schmidt P; Diener HC Headache; 2017 May; 57(5):756-765. PubMed ID: 28386945 [TBL] [Abstract][Full Text] [Related]
26. Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study. Takeshima T; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Matsumori Y; Hirata K Adv Ther; 2022 Nov; 39(11):5176-5190. PubMed ID: 36089637 [TBL] [Abstract][Full Text] [Related]
27. Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks. Lee JH; Shewale AR; Barthold D; Devine B Headache; 2021 Nov; 61(10):1499-1510. PubMed ID: 34841520 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Buse DC; Reed ML; Fanning KM; Kurth T; Lipton RB Headache; 2017 Jan; 57(1):31-44. PubMed ID: 27861837 [TBL] [Abstract][Full Text] [Related]
29. Poor medical care for people with migraine in Europe - evidence from the Eurolight study. Katsarava Z; Mania M; Lampl C; Herberhold J; Steiner TJ J Headache Pain; 2018 Feb; 19(1):10. PubMed ID: 29392600 [TBL] [Abstract][Full Text] [Related]
30. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833 [TBL] [Abstract][Full Text] [Related]
31. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422 [TBL] [Abstract][Full Text] [Related]
32. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745 [TBL] [Abstract][Full Text] [Related]
33. Drugs for the acute treatment of migraine in children and adolescents. Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010 [TBL] [Abstract][Full Text] [Related]
34. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165 [TBL] [Abstract][Full Text] [Related]
35. Triptans for Acute Migraine Headache: Current Experience With Triptan Use and Prescription Habits in a Tertiary Care Headache Outpatient Clinic: An Observational Study. Fischer M; Frank F; Wille G; Klien S; Lackner P; Broessner G Headache; 2016 Jun; 56(6):952-60. PubMed ID: 27091593 [TBL] [Abstract][Full Text] [Related]
36. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study. Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844 [TBL] [Abstract][Full Text] [Related]
37. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Martin VT; Fanning KM; Serrano D; Buse DC; Reed ML; Bernstein JA; Lipton RB Cephalalgia; 2014 Apr; 34(5):336-48. PubMed ID: 24275145 [TBL] [Abstract][Full Text] [Related]
38. Characterizing opioid use in a Dutch cohort with migraine. van Welie RF; van Welie FC; de Vries Lentsch S; Dahan A; van Velzen M; Terwindt GM Cephalalgia; 2023 May; 43(5):3331024231174160. PubMed ID: 37165775 [TBL] [Abstract][Full Text] [Related]
39. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694 [TBL] [Abstract][Full Text] [Related]
40. The acute treatment of episodic and chronic migraine in the USA. Bigal ME; Borucho S; Serrano D; Lipton RB Cephalalgia; 2009 Aug; 29(8):891-7. PubMed ID: 19222509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]